GlassScriptPhysician profile
Steven Corey Effren
NPI 1669555892
$4,839.31
in general payments reported to CMS, 2019-2025
19 companies · $279 in 2025
The $279 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,042 · 2020: $869 · 2021: $1,106 · 2022: $182 · 2023: $166 · 2024: $195 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $640.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,457.30 | 2019-2020 | |
| Stryker Corporation | $957.01 | 2021-2022 | |
| Organogenesis INC. | $327.10 | 2020-2024 | Affinity, Apligraf, Puraply Wound Matrix |
| Depuy Synthes Sales INC. | $201.91 | 2020-2025 | Motoband, Motoband Cp, Na |
| Wright Medical Technology, INC. | $132.83 | 2020 | |
| Smith+Nephew, INC. | $127.76 | 2019-2022 | |
| Kuros Biosciences USA, INC | $102.25 | 2025 | Magnetos |
| Orthofix Medical, INC. | $93.66 | 2020 | |
| Paragon 28, INC. | $75.97 | 2023 | Portfolio |
| Horizon Therapeutics Plc | $68.36 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $54.92 | 2022-2023 | Seglentis |
| Convatec INC. | $54.82 | 2023-2024 | |
| Averitas Pharma INC. | $53.44 | 2024 | Qutenza |
| Integra Lifesciences Corporation | $40.02 | 2019-2022 | |
| Kerecis Limited | $22.92 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $19.73 | 2022 | |
| Mimedx Group, INC. | $18.32 | 2025 | |
| Aroa Biosurgery Incorporated | $17.42 | 2022 | |
| Kci USA, INC. | $13.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Effren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.